Target intelligence / Profile preview

TAF12 divergent transcript (TAF12-DT)

Target
TAF12-DT
Molecular classification
long non-coding RNA (lncRNA), divergent transcript
01

Overview

TAF12 divergent transcript (TAF12-DT) is a human long non-coding RNA (lncRNA) located close to the TAF12 gene. HGNC defines "divergent transcript" as a lncRNA gene located 300–500 nucleotides from a protein-coding gene, typically in the opposite direction. TAF12-DT is predicted to participate in the recognition of 5'-splice sites during mRNA processing, possibly by binding pre-mRNA, but it is not a classical protein, enzyme, or receptor, and does not have a canonical role in signal transduction, cell cycle, apoptosis, or disease pathways. No known drugs target TAF12-DT, nor is it established as a biomarker or associated with safety concerns. TAF12-DT is not a conventional drug target and should not be confused with its neighboring protein-coding gene, TAF12 (TATA-box binding protein associated factor 12), which is a transcription factor involved in the TFIID complex. The target in question (TAF12-DT) functions at the RNA level, likely in pre-mRNA splicing rather than direct modulation of cellular pathways relevant to pharmacology or therapeutics.

Other names
TAF12-DTTAF12 divergent transcript
02

Biological functions

predicted to enable pre-mRNA 5'-splice site binding activitypredicted to be involved in mRNA 5'-splice site recognition

Beyond the preview

Go deeper on TAF12 divergent transcript (TAF12-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAF12 divergent transcript (TAF12-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call